Article
Erdheim–Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances
29 May 2017
Abstract excerpt
The revised 2016 World Health Organization classification introduced Erdheim-Chester disease (ECD) as a provisional entity within the histiocytic and dendritic cell neoplasms separate from the juvenile xanthogranuloma family based on distinct molecular features. However, evolving knowledge regarding the molecular and genetic aberrations in addition to common clinical features of ECD support the classification of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
